Ajax-Loading

Merck & Company Inc - Long Term Debt

Merck & Company Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Long-Term-Debt" stands at 39.97 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.

As of the end of Merck & Company Inc's third quarter, the item "Long Term Debt" stands at 39.97 Billion USD. This represents an increase of 17.67 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 14.26 percent compared to the value the year prior.
The 1 year change in percent is 14.26.
The 3 year change in percent is 40.33.
The 5 year change in percent is 51.85.
The 10 year change in percent is 65.68.

The Serie's long term average value is 24.05 Billion United States Dollars. It's latest available value, on 09/30/2025, is 66.20 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2012, to it's latest available value, on 09/30/2025, is +165.45%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.

Long Term Debt for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Long Term Debt905,699,262,464.00
LogoJohnson & Johnson - Long Term Debt486,508,953,600.00
LogoAbbVie Inc - Long Term Debt399,570,305,024.00
LogoRoche Holding AG - Long Term Debt317,433,206,677.55
LogoAstraZeneca PLC - Long Term Debt280,205,508,085.11